The latest reformulation of the #1 prescribed augmentation therapy in the US for people with alpha-1 antitrypsin deficiency, an often fatal lung disease.
Prolastin C
Eye-catching advertising and design
The latest reformulation of the #1 prescribed augmentation therapy in the US for people with alpha-1 antitrypsin deficiency, an often fatal lung disease.